Jump to Main Content
The immunogenicity of the secretory GΔTM protein of bovine ephemeral fever virus stably expressed by mammalian cells
- Hansoongnern, Payuda, Kaewborisuth, Challika, Wasanasuk, Ketkaew, Chankeeree, Penpitcha, Poonsuk, Sukontip, Lekcharoensuk, Chalermpol, Lekcharoensuk, Porntippa
- Veterinary microbiology 2019 v.233 pp. 113-117
- Bovine ephemeral fever virus, G-proteins, Lentivirus, antibodies, beef cattle, beef production, blood serum, buffaloes, cattle diseases, disease prevention, guinea pigs, immunogenicity, milk production, neutralization, subunit vaccines, vaccination, vaccine development
- Bovine ephemeral fever virus (BEFV) causes an acute febrile disease in cattle and water buffalo. The disease has an impact on dairy and beef production in tropical and subtropical countries. Vaccination is used for disease prevention and control. In this study, we developed a recombinant lentivirus to produce mammalian stable cells expressing histidine-tagged BEFV G protein with a deleted transmembrane domain (GΔTM) as a secretory protein. In addition, guinea pigs were immunised with the purified GΔTM protein and booster immunised at a 3-week interval. The mammalian stable cells were able to continuously produce GΔTM protein for a minimum of 25 passages. All of the mammalian stable cells expressing GΔTM protein could react specifically with a BEFV convalescent bovine serum. Serum samples from the immunised guinea pigs could react strongly and specifically with the purified GΔTM protein. Moreover, post-immunised guinea pig sera contained antibodies that could neutralise BEFV. These results indicate that the G protein without a transmembrane domain can be used as a subunit vaccine for the prevention and control of BEFV. The availability of the mammalian stable cells, which constitutively express GΔTM protein, could facilitate the potential use of the secretory protein for BEFV diagnosis and vaccine development.